Senate Life Science Private Limited
About Senate Life Science Private Limited
Data last updated:
Senate Life Science Private Limited is a private limited company based in Delhi, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 28 December 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC409006.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sushant Acharya and Santosh Kumar Acharya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dpt – 320 DLF Prime Tower Plot No. 79 – 80 Okhla Phase – 1 Industrial Area, Delhi, India – 110020.
As per the financials filed for FY 2023, the company reported a revenue of ₹66.6 Lakh. For the same year it recorded a net profit of ₹17.79 Lakh (net margin 26.7%) and EBITDA of ₹23.78 Lakh (EBITDA margin 35.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Senate Life Science Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDpt – 320 DLF Prime Tower Plot No. 79 – 80 Okhla Phase – 1 Industrial Area, Delhi, India – 110020
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Senate Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Senate Life Science Private Limited
FY 2025 filings availableSenate Life Science Private Limited reported revenue of ₹66.6 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹66.6 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹23.78 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹17.79 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | 35.7% |
| Net Profit Margin | 26.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Senate Life Science Private Limited, buy the company report.
Board of directors of Senate Life Science Private Limited
Senate Life Science has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Acharya Also directs: Senate Solution Private Limited | Additional Director | 08 Oct 2024 | 2 Years 1 Months | Current |
| Sushant Acharya | Director | 28 Dec 2022 | 3 Years 10 Months | Current |
Auditor
Senate Life Science Private Limited is audited by Sanjay Dutt & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sanjay Dutt & Associates | FY 2023 | 037678N |
Shareholding
The shareholding of Senate Life Science Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Senate Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Senate Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Senate Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Senate Life Science Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Senate Life Science Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Santosh Kumar Acharya was appointed as Additional Director on 08 Oct 2024.
Frequently asked questions
Senate Life Science is an active private limited company based in Delhi, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 28 December 2022 (4+ years old) and is registered under CIN U24290DL2022PTC409006.
Senate Life Science has 2 current directors:
- Santosh Kumar Acharya - Additional Director
- Sushant Acharya - Director
The latest financial statements of Senate Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Senate Life Science is U24290DL2022PTC409006. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Senate Life Science was incorporated on 28 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Santosh Kumar Acharya was appointed as Additional Director on 08 Oct 2024. Ratneshwar Dutta ceased to be Additional Director on 06 Sep 2024. Saurabh Bansal ceased to be Director on 27 Jun 2023. Senate Life Science has 4 board changes on record in total.
The registered office of Senate Life Science is at Dpt – 320 DLF Prime Tower Plot No. 79 – 80 Okhla Phase – 1 Industrial Area, Delhi, India – 110020.
Senate Life Science operates in the chemicals and materials industry, in the chemical distribution and retail segment.
The compliance status of Senate Life Science is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Senate Life Science can be reached at its registered office: Dpt – 320 DLF Prime Tower Plot No. 79 – 80 Okhla Phase – 1 Industrial Area, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
